Comparing overdose prevention centers in New York City and Rhode Island
A comparative evaluation of overdose prevention programs in New York City and Rhode Island
This project compares how supervised overdose prevention centers in New York City and Rhode Island affect people's health, safety, and access to treatment and services.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11305996 on NIH RePORTER |
What this research studies
If you join, researchers will follow people who use drugs who visit the first publicly recognized overdose prevention centers in NYC and Rhode Island over several years. They plan to enroll about 500 people who use these centers and track outcomes like overdoses, emergency room visits, other health problems, and whether you start substance use treatment. The team will also look at neighborhood and community measures to see how the centers affect public health and safety and whether there are any unintended effects. They will use interviews, medical records, and local public-safety data to understand both individual and community impacts.
Who could benefit from this research
Good fit: Ideal participants are adults who use pre-obtained controlled substances and attend the overdose prevention centers in New York City or Rhode Island.
Not a fit: People who do not use drugs, live outside New York City or Rhode Island, or who never attend these centers are unlikely to directly benefit from participating.
Why it matters
Potential benefit: If successful, this could show whether these centers reduce overdoses, connect people to care, and improve community safety.
How similar studies have performed: Studies of similar centers in other countries have shown reduced overdoses and safer use, but U.S.-based evidence from publicly recognized centers is limited.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Allen, Bennett — New York University School of Medicine
- Study coordinator: Allen, Bennett
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.